Cefixime in urinary tract infections with special reference to pediatrics: Overview

Journal of Chemotherapy

Volumn 13, Issue 2, 2001, Pages 112-117

  Fanos, V ^a   Cataldi, L ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Cefixime; Pediatrics; Urinary tract infections

Indexed keywords

CEFIXIME; CEFTRIAXONE; COTRIMOXAZOLE;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; NEPHROTIC SYNDROME; REVIEW; URINARY TRACT INFECTION;

EID: 0035046112     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.2.112     Document Type: Review

References (48)

1. The pharmacokinetic and bactericidal characteristics of oral cefixime
2. Cefixime
3. Cefixime: Spectrum of antibacterial activity against 16016 clinical isolates
4. Cefixime: A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential
5. In vitro activity of a new broad spectrum, betalactamase: Stable oral cephalosporin, cefixime
6. The activity of cefixime against 715 urinary isolates of Enterobacteriaceae isolated from general practice and outpatients in twenty centres across the British Isles
7. Bacteriological comparison of cefixime in patients with in Spain. Preliminary results
8. Etude comparant le cefixime a l'association amoxicilline-acide clavulanique dans le traitement par vole orale des infections urinaires de l'enfant
9. Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens
10. Comparative in vitro activity and β-lactamase stability of FR-17027, a new orally active cephalosporin
11. Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady-state
12. Clinical experience with cefixime in the pediatric infections
13. Pharmacokinetic profile of cefixime in man
14. Pharmacokinetics of cefixime in healthy subjects and patients with renal insufficiency
15. Safety profile of cefixime
16. Efficacy and tolerability of cefixime in international and French studies
17. Clinical studies on cefixime in pediatrics
18. Noncomparative, open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients
19. Nephrotic syndrome following cefixime therapy in a 10-month-old girl: Spontaneous resolution without corticosteroid treatment
20. Cefixime in urinary tract infections
21. Single dose oral administration of cefixime 400 mg in the treatment of acute uncomplicated cystitis and gonorrhoea
22. Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women
23. In vitro activity and clinical evaluation of cefixime in urinary tract infection
24. Efficacy and tolerability of cefixime in urinary tract infections in adults. A French multicentric study
25. A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients
26. Cefixime versus trimethoprim/sulfamethoxazole in treatment of patients with acute, uncomplicated lower urinary tract infections
27. Effectiveness and tolerance of cefixime in the treatment of acute pyelonephritis
28. Clinical pharmacokinetics in infants and children: A reappraisal
29. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose
30. Pharmacokinetics and clinical effects of cefixime in pediatrics
31. Therapy of pediatric infections with cefixime
32. Assessment of the efficacy and cost efficiency of two strategies in the treatment or acute pyelonephritis in children: Oral cefixime or parenteral ceftriaxone after an initial iv combination therapy
33. Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections
34. Cefixime for switch therapy
35. Management of pyelonephritis and upper urinary tract infections
36. Oral versus initial intravenous therapy far urinary tract infections in young febrile children
37. Cefixime therapy for paediatric urinary tract infections
38. Once-daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children
39. Effectiveness and tolerance of cefixime in bacterial urinary tract infections in patients with myelomeningocele
40. Antibiotic treatment of infections in neonates: A review
41. Antibiotic prophylaxis in children with urinary tract infections
42. Urinary biomarkers in children with urinary tract infections with and without reflux on antibiotic prophylaxis with cefaclor
43. Antibacterial induced nephrotoxicity in the newborn
44. Evaluation of antibiotic-induced nephrotoxicity in preterm newborns by determining urinary alphalmicroglobulin
45. Urinary low molecular mass protein and enzymes as early non-invasive markers of nephrotoxicity in the neonate
46. Growth factors and their relationship to development of renal function in the neonate
47. Urinary excretion of human Epidermal Growth Factor (hEGF) in premature infants requiring assisted ventilation over the first week of life
48. Antimicrobial survey on urinary tract isolated microorganisms in a pediatric department